These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30864910)

  • 1. Re: Epigenetic Silencing of the Dual-Role Signal Mediator, ANGPTL4 in Tumor Tissues and Its Overexpression in the Urothelial Carcinoma Microenvironment.
    Atala A
    J Urol; 2019 Jun; 201(6):1057. PubMed ID: 30864910
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: HER2 as a Target in Invasive Urothelial Carcinoma.
    Chang SS
    J Urol; 2016 Dec; 196(6):1637-1639. PubMed ID: 27845103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current classification of urothelial (transitional cell) carcinoma and its variants].
    Cheng L; Xu JW; Zheng SQ; Sun YL; Ma YY; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):197-201. PubMed ID: 18788601
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival.
    Jou YC; Tsai YS; Chen SY; Hsieh HY; Tsai HT; Tzai TS
    Virchows Arch; 2016 Jun; 468(6):733-40. PubMed ID: 27003158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
    Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N
    Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental bases of urothelial carcinogenesis].
    Chopin D; Cappellen D; Fradvanyi F; Gattegno B
    Prog Urol; 2001 Nov; 11(5):879-924. PubMed ID: 11769084
    [No Abstract]   [Full Text] [Related]  

  • 8. Nuclear size measurement for distinguishing urothelial carcinomas from reactive urothelium on tissue sections.
    Poropatich K; Yang JC; Goyal R; Parini V; Yang XJ
    Diagn Pathol; 2016 Jun; 11(1):57. PubMed ID: 27357719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mitomycin formulation for low-grade upper tract urothelial cancer.
    Dreicer R
    Lancet Oncol; 2020 Jun; 21(6):735-736. PubMed ID: 32631490
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urothelial carcinomas of the upper tract: the myth became a reality].
    Rouprêt M; Colin P
    Prog Urol; 2014 Nov; 24(15):939-42. PubMed ID: 25195030
    [No Abstract]   [Full Text] [Related]  

  • 11. Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome.
    Barocas DA; Kawamoto H; Dreizin DF; Howard ME; Choi J; Pitts WR; You X; Tickoo SK; Boorjian SA; Scherr DS
    Urology; 2005 Nov; 66(5):1134-9. PubMed ID: 16286153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathologist at the core of the new classification for urothelial carcinomas].
    Molinié V
    Ann Pathol; 2016 Aug; 36(4):233-4. PubMed ID: 27521982
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of drug development in urothelial cancer.
    Dreicer R
    J Clin Oncol; 2012 Feb; 30(5):473-5. PubMed ID: 22184400
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Trials Referral Resource. Clinical trials in bladder and urothelial cancers.
    Kaplan RS; Cheson BD; Nelson AP
    Oncology (Williston Park); 1997 Sep; 11(9):1348, 1351. PubMed ID: 9306423
    [No Abstract]   [Full Text] [Related]  

  • 15. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From new genetic and histological classifications to direct treatment].
    Compérat E; Furudoï A; Varinot J; Rioux-Leclerq N
    Ann Pathol; 2016 Aug; 36(4):275-8. PubMed ID: 27474530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modern management of upper tract urothelial cancer: surgical treatment.
    Arancibia MF; Bolenz C; Michel MS; Keeley FX; Alken P
    BJU Int; 2007 May; 99(5):978-81. PubMed ID: 17437429
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanical Implantation of Urothelium Into Periureteral Soft Tissue: A Series of 4 Cases Mimicking High-stage Urothelial Carcinoma.
    Wobker SE; Aron M; Epstein JI
    Am J Surg Pathol; 2016 Nov; 40(11):1564-1570. PubMed ID: 27631511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
    Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
    BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of programmed cell death protein 4 (PDCD4) and miR-21 in urothelial carcinoma.
    Fischer N; Göke F; Splittstösser V; Lankat-Buttgereit B; Müller SC; Ellinger J
    Biochem Biophys Res Commun; 2012 Jan; 417(1):29-34. PubMed ID: 22133680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.